3 cycles chemotherapy

DRUG2 trials

Sponsors

Sun Yat-sen University

Conditions

Retinoblastoma

Phase 3

Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation

Active, not recruitingNCT01906814

Sun Yat-sen UniversityRetinoblastoma

Start: 2013-08-31End: 2024-04-30Updated: 2024-04-09

Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma

RecruitingNCT05080010

Sun Yat-sen UniversityRetinoblastoma

Start: 2020-11-01End: 2030-12-31Target: 500Updated: 2021-10-15

Related Papers

Three vs 6 Cycles of Chemotherapy for High-Risk Retinoblastoma

JAMA2024-10-2112 citations